天坛生物人凝血酶原复合物近日正式开展Ⅲ期临床试验

Core Viewpoint - Tian Tan Biological announced the initiation of Phase III clinical trials for its "Prothrombin Complex Concentrate," developed by its subsidiary Wuhan Biological Pharmaceutical, following the completion of ethical review and preparatory work for clinical enrollment [1] Group 1: Product Development - The Prothrombin Complex Concentrate is primarily used for the treatment of congenital and acquired deficiencies of coagulation factors II, VII, IX, and X, which include conditions such as Hemophilia B, anticoagulant overdose, and vitamin K deficiency [1]